January 2016 Analysis

Industry Trend Analysis - Balancing Protection And Access Essential For EU Biosimilar Market To Succeed - JAN 2016

Despite biosimilars having now been available in the EU for some years, there is still scope to produce international-level guidelines on implementing and maintaining a competitive market. The EFPIA is seizing the initiative and in doing so has given itself the ability to influence the emerging market. Key concerns raised reflect debate in the US and elsewhere; finding the balance between...